Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer

PURPOSE: Recently, a 36-kDa variant of estrogen receptor α (ER-α66), ER-α36, has been identified and cloned. ER-α36 predominantly localizes on the plasma membrane and in the cytoplasm and mediates a membrane-initiated “nongenomic” signaling pathway. Here, we investigate the association between ER-α3...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shi, Liang, Dong, Bin, Li, Zhongwu, Lu, Yunwei, Ouyang, Tao, Li, Jinfeng, Wang, Tianfeng, Fan, Zhaoqing, Fan, Tie, Lin, Benyao, Wang, Zhaoyi, Xie, Yuntao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2717750/
https://ncbi.nlm.nih.gov/pubmed/19487384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.2254
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak